176 related articles for article (PubMed ID: 36061189)
1. Molecular characteristics of immunocytes infiltration in primary central nervous system lymphoma.
Zhang L; Sun F; Lu X; Wang X; Wang J; Li J; Xu Y; Kou D; Lv H; Don B
Front Genet; 2022; 13():921823. PubMed ID: 36061189
[No Abstract] [Full Text] [Related]
2. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
[TBL] [Abstract][Full Text] [Related]
3. Analyzing the characteristics of immune cell infiltration in lung adenocarcinoma via bioinformatics to predict the effect of immunotherapy.
Liao Y; He D; Wen F
Immunogenetics; 2021 Oct; 73(5):369-380. PubMed ID: 34302518
[TBL] [Abstract][Full Text] [Related]
4. Verification of genetic differences and immune cell infiltration subtypes in the neuroblastoma tumour microenvironment during immunotherapy.
Qian B; Sun J; Zuo P; Da M; Mo X; Fang Y
World J Surg Oncol; 2022 May; 20(1):169. PubMed ID: 35643506
[TBL] [Abstract][Full Text] [Related]
5. Landscape of Immune Microenvironment Under Immune Cell Infiltration Pattern in Breast Cancer.
Xu Q; Chen S; Hu Y; Huang W
Front Immunol; 2021; 12():711433. PubMed ID: 34512634
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of immune cell infiltration and significant genes in head and neck squamous cell carcinoma.
Zhang S; Zhang W; Zhang J
Oral Oncol; 2022 Mar; 126():105755. PubMed ID: 35144208
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of the Immune Cell Infiltration Landscape in Gastric Cancer to Assistant Immunotherapy.
Li C; Pan J; Jiang Y; Yu Y; Jin Z; Chen X
Front Genet; 2021; 12():793628. PubMed ID: 35069691
[No Abstract] [Full Text] [Related]
8. Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma.
Takashima Y; Hamano M; Yoshii K; Hayano A; Fukai J; Iwadate Y; Kajiwara K; Hondoh H; Yamanaka R
Int J Clin Oncol; 2023 Mar; 28(3):468-481. PubMed ID: 36607476
[TBL] [Abstract][Full Text] [Related]
9. The immune contexture of primary central nervous system diffuse large B cell lymphoma associates with patient survival and specific cell signaling.
Alame M; Cornillot E; Cacheux V; Rigau V; Costes-Martineau V; Lacheretz-Szablewski V; Colinge J
Theranostics; 2021; 11(8):3565-3579. PubMed ID: 33664848
[No Abstract] [Full Text] [Related]
10. Characterization of the Immune Cell Infiltration Landscape in Esophageal Squamous Cell Carcinoma.
Sui Z; Wu X; Du L; Wang H; Yuan L; Zhang JV; Yu Z
Front Oncol; 2022; 12():879326. PubMed ID: 35875070
[TBL] [Abstract][Full Text] [Related]
11. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
[TBL] [Abstract][Full Text] [Related]
12. Construction of an Immune Cell Infiltration Score to Evaluate the Prognosis and Therapeutic Efficacy of Ovarian Cancer Patients.
Liu J; Wang Y; Yuan S; Wei J; Bai J
Front Immunol; 2021; 12():751594. PubMed ID: 34745124
[TBL] [Abstract][Full Text] [Related]
13. Identification and quantification of immune infiltration landscape on therapy and prognosis in left- and right-sided colon cancer.
Guo JN; Chen D; Deng SH; Huang JR; Song JX; Li XY; Cui BB; Liu YL
Cancer Immunol Immunother; 2022 Jun; 71(6):1313-1330. PubMed ID: 34657172
[TBL] [Abstract][Full Text] [Related]
14. Emerging Landscape of Immunotherapy for Primary Central Nervous System Lymphoma.
Alcantara M; Fuentealba J; Soussain C
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680209
[TBL] [Abstract][Full Text] [Related]
15. Influence of methotrexate exposure on outcome in patients treated with MBVP chemotherapy for primary central nervous system lymphoma.
Blasco H; Senecal D; Le Gouge A; Pinard E; Benz-de Bretagne I; Colombat P; Hulot JS; Chatelut E; Le Guellec C
Br J Clin Pharmacol; 2010 Sep; 70(3):367-75. PubMed ID: 20716237
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Cellular Heterogeneity in Immune Microenvironment of Primary Central Nervous System Lymphoma by Single-Cell Sequencing.
Wei B; Liu Z; Fan Y; Wang S; Dong C; Rao W; Yang F; Cheng G; Zhang J
Front Oncol; 2021; 11():683007. PubMed ID: 34671548
[TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas.
Ferreri AJ; Dell'Oro S; Capello D; Ponzoni M; Iuzzolino P; Rossi D; Pasini F; Ambrosetti A; Orvieto E; Ferrarese F; Arrigoni G; Foppoli M; Reni M; Gaidano G
Br J Haematol; 2004 Sep; 126(5):657-64. PubMed ID: 15327516
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Ovarian Cancer Immune Cell Invasion and Bioinformatics to Predict the Effect of Immunotherapy.
Yan L; Fan E; Tan B
Horm Metab Res; 2024 Mar; 56(3):197-205. PubMed ID: 38242159
[TBL] [Abstract][Full Text] [Related]
19. Establishment of an Immune Cell Infiltration Score to Help Predict the Prognosis and Chemotherapy Responsiveness of Gastric Cancer Patients.
Jiang Q; Sun J; Chen H; Ding C; Tang Z; Ruan Y; Liu F; Sun Y
Front Oncol; 2021; 11():650673. PubMed ID: 34307129
[TBL] [Abstract][Full Text] [Related]
20. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL).
Bergner N; Monsef I; Illerhaus G; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Nov; 11():CD009355. PubMed ID: 23152274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
